Your browser doesn't support javascript.
loading
The effect of shortening vasoactive drug durations alongside endoscopic therapy in esophageal variceal bleeding: an updated systematic review and meta-analysis.
Dhoop, Sudheer; Ahmed, Zohaib; Lombardi, Conner; Abu-Rumaileh, Mohammed; Arif, Syeda Faiza; Sayeh, Wasef; Patel, Rayna; Sherafati, Alborz; Lee-Smith, Wade; Hassan, Mona.
Afiliación
  • Dhoop S; Department of Internal Medicine, University of Toledo College of Medicine and Life Sciences (Sudheer Dhoop, Conner Lombardi, Mohammed Abu-Rumeileh, Syeda Faiza Arif, Wasef Sayeh, Rayna Patel, Alborz Sherafati).
  • Ahmed Z; Department of Gastroenterology and Hepatology, University of Toledo College of Medicine and Life Sciences (Zohaib Ahmed, Mona Hassan).
  • Lombardi C; Department of Internal Medicine, University of Toledo College of Medicine and Life Sciences (Sudheer Dhoop, Conner Lombardi, Mohammed Abu-Rumeileh, Syeda Faiza Arif, Wasef Sayeh, Rayna Patel, Alborz Sherafati).
  • Abu-Rumaileh M; Department of Internal Medicine, University of Toledo College of Medicine and Life Sciences (Sudheer Dhoop, Conner Lombardi, Mohammed Abu-Rumeileh, Syeda Faiza Arif, Wasef Sayeh, Rayna Patel, Alborz Sherafati).
  • Arif SF; Department of Internal Medicine, University of Toledo College of Medicine and Life Sciences (Sudheer Dhoop, Conner Lombardi, Mohammed Abu-Rumeileh, Syeda Faiza Arif, Wasef Sayeh, Rayna Patel, Alborz Sherafati).
  • Sayeh W; Department of Internal Medicine, University of Toledo College of Medicine and Life Sciences (Sudheer Dhoop, Conner Lombardi, Mohammed Abu-Rumeileh, Syeda Faiza Arif, Wasef Sayeh, Rayna Patel, Alborz Sherafati).
  • Patel R; Department of Internal Medicine, University of Toledo College of Medicine and Life Sciences (Sudheer Dhoop, Conner Lombardi, Mohammed Abu-Rumeileh, Syeda Faiza Arif, Wasef Sayeh, Rayna Patel, Alborz Sherafati).
  • Sherafati A; Department of Internal Medicine, University of Toledo College of Medicine and Life Sciences (Sudheer Dhoop, Conner Lombardi, Mohammed Abu-Rumeileh, Syeda Faiza Arif, Wasef Sayeh, Rayna Patel, Alborz Sherafati).
  • Lee-Smith W; University Libraries, University of Toledo (Wade Lee-Smith), Toledo, OH, USA.
  • Hassan M; Department of Gastroenterology and Hepatology, University of Toledo College of Medicine and Life Sciences (Zohaib Ahmed, Mona Hassan).
Ann Gastroenterol ; 37(5): 567-578, 2024.
Article en En | MEDLINE | ID: mdl-39238793
ABSTRACT

Background:

The recommended duration of vasoactive drugs in esophageal variceal bleeding (EVB) spans 2-5 days. Prior meta-analyses of randomized trials include only a few studies that compared short vs. long vasoactive drug durations approximating this time range, including older management techniques, and only assessed variceal rebleeding at 5 days. We identified several additional randomized controlled trials (RCTs) assessing rebleeding at various durations, with updated management of EVB.

Methods:

We performed an updated systematic review and meta-analysis assessing the effect of shortening the vasoactive drug duration by 48-72 h. The primary outcome was rebleeding within 5 days. Secondary outcomes included rebleeding, mortality due to rebleeding, and all-cause mortality within 4-6 weeks (extended period) with subgroup analysis by vasoactive drug and type of endoscopic therapy. Length of stay, blood transfusion requirements and terlipressin-related adverse events were additional secondary outcomes.

Results:

Our comprehensive search strategy and screening process yielded 14 RCTs with 1060 patients (75.1% male) 7 trials used terlipressin, 4 octreotide, and 3 somatostatin. Shortened durations combined with band ligation led to similar rebleeding, with a trend towards less rebleeding when populations with more severe liver disease were excluded. There was greater rebleeding and mortality over an extended period when shorter durations were combined with sclerotherapy. Longer durations were associated with a longer hospital stay and, for terlipressin, more adverse events.

Conclusions:

Shorter vasoactive drug durations combined with band ligation in selected populations appear safe. Higher powered RCTs are needed, involving patients with different degrees of severity of EVB and liver disease.
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Ann Gastroenterol Año: 2024 Tipo del documento: Article Pais de publicación: Grecia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Ann Gastroenterol Año: 2024 Tipo del documento: Article Pais de publicación: Grecia